Latest Research
The PROUD Study: Examining the impact on gay men of using Pre-Exposure Prophylaxis (PrEP)
March 11 2013
PrEPis a way of reducing the risk of HIV transmission. It involves HIV negative people taking a daily tablet (Truvada) that contains drugs commonly used to treat HIV (tenofovir and emtricitabine). Previous studies with gay men found that using PrEPalmost …
The START Study
March 11 2013
The Strategic Timing of Anti-Retroviral Treatment or START study compares the risks and benefits of starting HIV medicines at CD4+ cell counts over 500/mm3 compared to waiting until CD4+ cell counts drop to 350/mm3 in people who are well. We …
Share This Page
Log In
Not a member? Join the Community now!
